What is a ‘natural’ dye, anyway?
Stat News • 2/6/2026
Summary
The news story titled "What is a ‘natural’ dye, anyway?" is part of today's Morning Rounds newsletter. It focuses on health-related topics.
Advertisement
Lindy Score Breakdown (V4.2)
57d
Age
1
Sources
from cluster
1374
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1374/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1374/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 57 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
Opinion: My patient would rather take a peptide than a statin. That reveals an uncomfortable truth in medicine
Stat News • 1 day ago
STAT+: Medicare Advantage plans win extra $18.6 billion as feds cut star ratings measures
Stat News • 1 day ago
Supreme Court conversion therapy decision could ripple through medicine
Stat News • 1 day ago
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Stat News • 2 days ago
STAT+: Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device?
Stat News • 2 days ago
EPA to put microplastics on study list of contaminants in drinking water
Stat News • 2 days ago
STAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along
Stat News • 1 day ago
Opinion: Medical misinformation wins when patients can’t see their doctors
Stat News • 2 days ago
Thursday was World Autism Awareness Day. HHS celebrated with…a workout?
Stat News • 1 day ago
Opinion: Subscription pricing could expand access to HIV prevention breakthrough while controlling costs
Stat News • 1 day ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 5 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago